$190 Million is the total value of DOHENY ASSET MANAGEMENT /CA's 96 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
NKE | New | NIKE INC CL B | $833,000 | – | 10,595 | +100.0% | 0.44% | – |
ECA | New | ENCANA CORP | $558,000 | – | 30,890 | +100.0% | 0.29% | – |
AXP | New | AMERICAN EXPRESS CO. | $227,000 | – | 2,500 | +100.0% | 0.12% | – |
GSK | New | GLAXOSMITHKLINE PLC | $214,000 | – | 4,000 | +100.0% | 0.11% | – |
RTN | New | RAYTHEON COMPANY | $202,000 | – | 2,223 | +100.0% | 0.11% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-02-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
APPLE INC COM | 41 | Q3 2023 | 14.9% |
MICROCHIP TECHNOLOGY INC | 41 | Q3 2023 | 4.2% |
JOHNSON & JOHNSON COM | 41 | Q3 2023 | 2.9% |
LXP INDUSTRIAL TRUST REIT | 41 | Q3 2023 | 3.7% |
CHECK PT SOFTWARE F | 41 | Q3 2023 | 3.8% |
GILEAD SCIENCES INC. | 41 | Q3 2023 | 4.2% |
MERCK & CO INC NEW | 41 | Q3 2023 | 2.6% |
STARBUCKS CORP COM | 41 | Q3 2023 | 2.6% |
HALOZYME THERAPEUTICS INC | 41 | Q3 2023 | 3.6% |
CHEVRON CORPORATION | 41 | Q3 2023 | 2.0% |
View DOHENY ASSET MANAGEMENT /CA's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-08 |
13F-HR | 2024-02-06 |
13F-HR | 2023-11-08 |
13F-HR | 2023-08-08 |
13F-HR | 2023-05-16 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-10 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-15 |
13F-HR | 2021-10-22 |
View DOHENY ASSET MANAGEMENT /CA's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.